{"id":"https://openalex.org/W2070063243","doi":"https://doi.org/10.1046/j.1365-2362.1997.2330779.x","title":"Can reduction in hypertriglyceridaemia slow progression of microalbuminuria in patients with non\u2010insulin\u2010dependent diabetes mellitus?","display_name":"Can reduction in hypertriglyceridaemia slow progression of microalbuminuria in patients with non\u2010insulin\u2010dependent diabetes mellitus?","alternate_titles":[],"publication_year":1997,"publication_date":"1997-12-01","ids":{"openalex":"https://openalex.org/W2070063243","doi":"https://doi.org/10.1046/j.1365-2362.1997.2330779.x","mag":"2070063243","pmid":"https://pubmed.ncbi.nlm.nih.gov/9466127"},"language":"en","primary_location":{"id":"doi:10.1046/j.1365-2362.1997.2330779.x","doi":"https://doi.org/10.1046/j.1365-2362.1997.2330779.x","is_oa":false,"landing_page_url":"https://doi.org/10.1046/j.1365-2362.1997.2330779.x","pdf_url":null,"source":{"id":"https://openalex.org/S153084679","display_name":"European Journal of Clinical Investigation","issn_l":"0014-2972","issn":["0014-2972","1365-2362"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Journal of Clinical Investigation","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2070063243"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://research.vumc.nl/en/publications/b0f238c3-dd60-4074-851e-4d6b1f0899a3","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5043315520","display_name":"Yvo Michiel Smulders","orcid":"https://orcid.org/0000-0002-6680-8649","observed_orcids":["https://orcid.org/0000-0002-6680-8649","https://orcid.org/0000-0002-5904-0264"]},"institutions":[{"id":"https://openalex.org/I4210105568","display_name":"OLVG","ror":"https://ror.org/01d02sf11","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I4210105568"]}],"countries":["NL"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Y. M. SMULDERS","raw_affiliation_strings":["Department of Internal Medicine, Onze Lieve Vrouwe Gasthuis, Amsterdam, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Internal Medicine, Onze Lieve Vrouwe Gasthuis, Amsterdam, The Netherlands","institution_ids":["https://openalex.org/I4210105568"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021451630","display_name":"Arne E. van Eeden","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210105568","display_name":"OLVG","ror":"https://ror.org/01d02sf11","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I4210105568"]}],"countries":["NL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"A. E. VAN EEDEN","raw_affiliation_strings":["Department of Internal Medicine, Onze Lieve Vrouwe Gasthuis, Amsterdam, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Internal Medicine, Onze Lieve Vrouwe Gasthuis, Amsterdam, The Netherlands","institution_ids":["https://openalex.org/I4210105568"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016620300","display_name":"Coen D.A. Stehouwer","orcid":"https://orcid.org/0000-0001-8752-3223","observed_orcids":["https://orcid.org/0000-0001-8752-3223"]},"institutions":[{"id":"https://openalex.org/I4405257531","display_name":"Amsterdam Cardiovascular Sciences","ror":"https://ror.org/05c9qnd49","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I4405257531"]},{"id":"https://openalex.org/I865915315","display_name":"Vrije Universiteit Amsterdam","ror":"https://ror.org/008xxew50","country_code":"NL","type":"education","lineage":["https://openalex.org/I865915315"]}],"countries":["NL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"C. D. A. STEHOUWER","raw_affiliation_strings":["Institute for Cardiovascular Research and Department of Medicine, Academisch Ziekenhuis Vrije Universiteit, Amsterdam, The Netherlands,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute for Cardiovascular Research and Department of Medicine, Academisch Ziekenhuis Vrije Universiteit, Amsterdam, The Netherlands,","institution_ids":["https://openalex.org/I4405257531","https://openalex.org/I865915315"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062116314","display_name":"Rob N.M. Weijers","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210105568","display_name":"OLVG","ror":"https://ror.org/01d02sf11","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I4210105568"]}],"countries":["NL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"R. N. M. WEIJERS","raw_affiliation_strings":["Department of Clinical Chemistry, Onze Lieve Vrouwe Gasthuis, Amsterdam, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Chemistry, Onze Lieve Vrouwe Gasthuis, Amsterdam, The Netherlands","institution_ids":["https://openalex.org/I4210105568"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049278871","display_name":"E.H. Slaats","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210105568","display_name":"OLVG","ror":"https://ror.org/01d02sf11","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I4210105568"]}],"countries":["NL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"E. H. SLAATS","raw_affiliation_strings":["Department of Clinical Chemistry, Onze Lieve Vrouwe Gasthuis, Amsterdam, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Chemistry, Onze Lieve Vrouwe Gasthuis, Amsterdam, The Netherlands","institution_ids":["https://openalex.org/I4210105568"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5053274031","display_name":"Joseph Silberbusch","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210105568","display_name":"OLVG","ror":"https://ror.org/01d02sf11","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I4210105568"]}],"countries":["NL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"J. SILBERBUSCH","raw_affiliation_strings":["Department of Internal Medicine, Onze Lieve Vrouwe Gasthuis, Amsterdam, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Internal Medicine, Onze Lieve Vrouwe Gasthuis, Amsterdam, The Netherlands","institution_ids":["https://openalex.org/I4210105568"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5043315520"],"corresponding_institution_ids":["https://openalex.org/I4210105568"],"apc_list":{"value":4100,"currency":"USD","value_usd":4100},"apc_paid":null,"fwci":1.5579,"has_fulltext":false,"cited_by_count":78,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.81122774,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":98},"biblio":{"volume":"27","issue":"12","first_page":"997","last_page":"1002"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10408","display_name":"Chronic Kidney Disease and Diabetes","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10408","display_name":"Chronic Kidney Disease and Diabetes","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10027","display_name":"Diabetes, Cardiovascular Risks, and Lipoproteins","score":0.0013000000035390258,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11029","display_name":"Renal Diseases and Glomerulopathies","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/hypertriglyceridemia","display_name":"hypertriglyceridemia","score":0.984000027179718},{"id":"https://openalex.org/keywords/microalbuminuria","display_name":"microalbuminuria","score":0.9860000014305115},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9369999766349792},{"id":"https://openalex.org/keywords/gemfibrozil","display_name":"gemfibrozil","score":0.968999981880188},{"id":"https://openalex.org/keywords/triglyceride-lowering","display_name":"triglyceride lowering","score":0.9139999747276306},{"id":"https://openalex.org/keywords/albumin-excretion","display_name":"albumin excretion","score":0.7749999761581421},{"id":"https://openalex.org/keywords/diabetic-nephropathy-progression","display_name":"diabetic nephropathy progression","score":0.8349999785423279},{"id":"https://openalex.org/keywords/fibrates","display_name":"fibrates","score":0.6399999856948853}],"concepts":[{"id":"https://openalex.org/C2781203188","wikidata":"https://www.wikidata.org/wiki/Q1676817","display_name":"Microalbuminuria","level":3,"score":0.8124602437019348},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.7248335480690002},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.721510648727417},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.7133282423019409},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.47586601972579956},{"id":"https://openalex.org/C2779306644","wikidata":"https://www.wikidata.org/wiki/Q2002370","display_name":"Insulin","level":2,"score":0.45864373445510864},{"id":"https://openalex.org/C164705383","wikidata":"https://www.wikidata.org/wiki/Q10379","display_name":"Cardiology","level":1,"score":0.38227319717407227}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000419","descriptor_name":"Albuminuria","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":true},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":true},{"descriptor_ui":"D003928","descriptor_name":"Diabetic Nephropathies","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005500","descriptor_name":"Follow-Up Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011897","descriptor_name":"Random Allocation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015228","descriptor_name":"Hypertriglyceridemia","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":true},{"descriptor_ui":"D015228","descriptor_name":"Hypertriglyceridemia","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D015248","descriptor_name":"Gemfibrozil","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D018450","descriptor_name":"Disease Progression","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":6,"locations":[{"id":"doi:10.1046/j.1365-2362.1997.2330779.x","doi":"https://doi.org/10.1046/j.1365-2362.1997.2330779.x","is_oa":false,"landing_page_url":"https://doi.org/10.1046/j.1365-2362.1997.2330779.x","pdf_url":null,"source":{"id":"https://openalex.org/S153084679","display_name":"European Journal of Clinical Investigation","issn_l":"0014-2972","issn":["0014-2972","1365-2362"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Journal of Clinical Investigation","raw_type":"journal-article"},{"id":"pmid:9466127","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9466127","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European journal of clinical investigation","raw_type":"Clinical Trial"},{"id":"pmh:oai:pure.amsterdamumc.nl:openaire_cris_publications/8f05ee5f-84ff-4685-9404-9d6dffd31e32","doi":null,"is_oa":false,"landing_page_url":"https://pure.amsterdamumc.nl/en/publications/8f05ee5f-84ff-4685-9404-9d6dffd31e32","pdf_url":null,"source":{"id":"https://openalex.org/S7407055222","display_name":"Pure Amsterdam UMC","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Smulders, Y M, van Eeden, A E, Stehouwer, C D A, Weijers, R N M, Slaats, E H & Silberbusch, J 1997, 'Can reduction in hypertriglyceridaemia slow progression of microalbuminuria in patients with non-insulin-dependent diabetes mellitus?', European journal of clinical investigation, vol. 27, pp. 997-1002. https://doi.org/10.1046/j.1365-2362.1997.2330779.x","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:pure.atira.dk:openaire_cris_publications/b0f238c3-dd60-4074-851e-4d6b1f0899a3","doi":null,"is_oa":true,"landing_page_url":"https://research.vumc.nl/en/publications/b0f238c3-dd60-4074-851e-4d6b1f0899a3","pdf_url":null,"source":{"id":"https://openalex.org/S7407055350","display_name":"Amsterdam UMC (VU Amsterdam) - Institutional Repository","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Smulders, Y M, van Eeden, A E, Stehouwer, C D A, Weijers, R N M, Slaats, E H & Silberbusch, J 1997, 'Can reduction in hypertriglyceridaemia slow progression of microalbuminuria in patients with non-insulin-dependent diabetes mellitus?', European Journal of Clinical Investigation, vol. 27, pp. 997-1002. https://doi.org/10.1046/j.1365-2362.1997.2330779.x","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:dare.ubvu.vu.nl:1871/24755","doi":null,"is_oa":false,"landing_page_url":"http://hdl.handle.net/1871/24755","pdf_url":null,"source":{"id":"https://openalex.org/S4306400546","display_name":"Digital Academic REpository of VU University Amsterdam (Vrije Universiteit Amsterdam)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I865915315","host_organization_name":"Vrije Universiteit Amsterdam","host_organization_lineage":["https://openalex.org/I865915315"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"27","raw_type":"Article / Letter to editor"},{"id":"pmh:vumc:oai:pure.atira.dk:publications/b0f238c3-dd60-4074-851e-4d6b1f0899a3","doi":null,"is_oa":true,"landing_page_url":"https://research.vumc.nl/en/publications/b0f238c3-dd60-4074-851e-4d6b1f0899a3","pdf_url":null,"source":{"id":"https://openalex.org/S4306401843","display_name":"Data Archiving and Networked Services (DANS)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1322597698","host_organization_name":"Royal Netherlands Academy of Arts and Sciences","host_organization_lineage":["https://openalex.org/I1322597698"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"European Journal of Clinical Investigation, 27, 997 - 1002","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":{"id":"pmh:oai:pure.atira.dk:openaire_cris_publications/b0f238c3-dd60-4074-851e-4d6b1f0899a3","doi":null,"is_oa":true,"landing_page_url":"https://research.vumc.nl/en/publications/b0f238c3-dd60-4074-851e-4d6b1f0899a3","pdf_url":null,"source":{"id":"https://openalex.org/S7407055350","display_name":"Amsterdam UMC (VU Amsterdam) - Institutional Repository","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Smulders, Y M, van Eeden, A E, Stehouwer, C D A, Weijers, R N M, Slaats, E H & Silberbusch, J 1997, 'Can reduction in hypertriglyceridaemia slow progression of microalbuminuria in patients with non-insulin-dependent diabetes mellitus?', European Journal of Clinical Investigation, vol. 27, pp. 997-1002. https://doi.org/10.1046/j.1365-2362.1997.2330779.x","raw_type":"info:eu-repo/semantics/article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2184315055","https://openalex.org/W3028062789","https://openalex.org/W2039245561","https://openalex.org/W4397036304","https://openalex.org/W2804634673","https://openalex.org/W3170352751","https://openalex.org/W2606704550","https://openalex.org/W2604047516","https://openalex.org/W2128717505","https://openalex.org/W2211200980"],"abstract_inverted_index":{"The":[0],"objective":[1],"of":[2,18,20,58,70,103,121,154,187,201,221,228],"this":[3],"study":[4],"was":[5,60,123,156],"to":[6,44,105,172,178,192],"investigate":[7],"whether":[8],"reduction":[9,116,149,204],"in":[10,22,90,109,117,130,136,150,160,205,215],"hypertriglyceridaemia":[11,34,104],"is":[12],"associated":[13,225],"with":[14,24,33,67,144,163,226],"a":[15,63,95,114],"slower":[16],"rate":[17],"progression":[19,153],"microalbuminuria":[21,40,59,122],"patients":[23,32,188],"non-insulin-dependent":[25],"diabetes":[26],"mellitus":[27],"(NIDDM).":[28],"Fifteen":[29],"normotensive":[30],"NIDDM":[31,217],"(>":[35,98],"2.5":[36],"mmol":[37],"L-1)":[38],"and":[39,73,83],"were":[41],"randomly":[42],"selected":[43],"receive":[45],"either":[46],"placebo":[47,111,138,191],"(eight":[48],"patients)":[49],"or":[50,99,146,165],"gemfibrozil":[51,193],"600":[52],"mg":[53],"b.i.d.":[54],"(seven":[55],"patients).":[56],"Progression":[57,120],"assessed":[61],"during":[62],"12-month":[64],"follow-up":[65,185],"period":[66],"measurements,":[68],"consisting":[69],"blood":[71],"tests":[72],"triplicate":[74],"24-h":[75],"urine":[76],"collections,":[77],"at":[78],"1,":[79],"3,":[80],"6,":[81],"9":[82],"12":[84],"months.":[85],"All":[86],"but":[87],"one":[88],"patient":[89,108],"the":[91,110,131,137,142,161,195,199,211],"treatment":[92,132,220],"group":[93,112,133,139,143,162],"showed":[94,113],"favourable":[96],"response":[97],"=":[100,147,182],"20%":[101,148],"reduction)":[102],"gemfibrozil.":[106],"One":[107],"spontaneous":[115],"triglyceride":[118,151,167,203],"levels.":[119],"lower,":[124],"although":[125],"not":[126],"statistically":[127],"significantly":[128,157],"so,":[129],"(36%)":[134],"than":[135,159],"(65%).":[140],"In":[141,209],">":[145],"levels,":[152],"MA":[155],"lower":[158],"stable":[164],"increasing":[166],"levels":[168],"(+1%,":[169],"range":[170,176],"-56%":[171],"+49%":[173],"vs.":[174],"+97%,":[175],"-35%":[177],"+202%":[179],"respectively)":[180],"(P":[181],"0.03).":[183],"Continued":[184],"data":[186],"switching":[189],"from":[190],"after":[194],"trial":[196],"further":[197],"support":[198],"role":[200],"serum":[202],"stabilizing":[206],"albumin":[207,230],"excretion.":[208,231],"conclusion,":[210],"results":[212],"indicate":[213],"that,":[214],"microalbuminuric":[216],"patients,":[218],"effective":[219],"dyslipidaemia":[222],"could":[223],"be":[224],"stabilization":[227],"urinary":[229]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2070063243","counts_by_year":[{"year":2022,"cited_by_count":1},{"year":2020,"cited_by_count":3},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":1},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":6},{"year":2012,"cited_by_count":6}],"updated_date":"2026-11-22T12:46:00.618207","created_date":"2016-06-24T00:00:00"}
